Organisation: Warner Chilcott PLC

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Number of Irish mergers and acquisitions down almost 50%

The number of Irish mergers, acquisitions and Equity capital market (ECM) transactions in Ireland declined by almost 50% in the first half of this year, according to figures released today.

business

Drugmaker shares slump as efforts to find buyer come to naught

news

Pharmaceutical firm hoping to create 200 jobs in new HQ

business

ISEQ makes modest gains

business

Elan and financials see ISEQ end week on positive note

business

ISEQ off to a positive start

Warner Chilcott secures FDA approval for Femtrace

ISEQ, FTSE and Nasdaq-listed Warner Chilcott has secured approval from the US Food & Drug Administration (FDA) for Femtrace™ tablets for the relief of the vasomotor symptoms (eg hot flashes, flushing) of menopause.

Mon, 23 Aug, 2004

Galen name change approved

Northern Ireland drug company Galen said its shareholders had “overwhelmingly approved” the change of the company's name to Warner Chilcott plc.

Sat, 26 Jun, 2004

All change at Galen as profits double

Pharmaceutical company Galen has seen pre-tax profits double to $48m (€40.38m) in Q2 and directors are to recommend a name change to shareholders at year's end to Warner Chilcott PLC.

Wed, 12 May, 2004